Soleno Therapeutics (SLNO) Operating Expenses (2013 - 2026)
Soleno Therapeutics (SLNO) posted quarterly Operating Expenses of $63.3 million for Q1 2026, up 38.44% year-over-year from $45.7 million in Q1 2025, and up 21.42% quarter-over-quarter from $52.2 million in Q4 2025.
Soleno Therapeutics (SLNO) Operating Expenses (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has reported Operating Expenses for 14 consecutive years, with $63.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 38.44% year-over-year to $63.3 million; the TTM figure through Mar 2026 stood at $198.6 million (down 5.41% YoY), while the FY2025 annual figure was $181.0 million, down 3.56% from the prior year.
- Operating Expenses climbed to $63.3 million in Q1 2026 per SLNO's latest filing, from $52.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $80.2 million in Q3 2024 and bottomed at $5.6 million in Q4 2022.
- Historically, Operating Expenses has averaged $29.3 million across 5 years, with a median of $23.5 million in 2024.
- Annual changes were most pronounced in 2024 — Operating Expenses soared 672.61% — and 2025, when it tumbled 45.25%.
- Soleno Therapeutics' Operating Expenses stood at $5.6 million in 2022, then soared by 147.95% to $13.9 million in 2023, then jumped by 324.99% to $59.1 million in 2024, then declined by 11.78% to $52.2 million in 2025, then rose by 21.42% to $63.3 million in 2026.
- Business Quant data shows SLNO's Operating Expenses at $63.3 million in Q1 2026, $52.2 million in Q4 2025, and $43.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Soleno Therapeutics | 2.74 Bn | 2.49 Bn | 93.41 Mn | 63.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.33 Mn |
| Dec 31, 2025 | 52.15 Mn |
| Sep 30, 2025 | 43.91 Mn |
| Jun 30, 2025 | 39.18 Mn |
| Mar 31, 2025 | 45.74 Mn |
| Dec 31, 2024 | 59.12 Mn |
| Sep 30, 2024 | 80.21 Mn |
| Jun 30, 2024 | 24.87 Mn |
| Mar 31, 2024 | 23.48 Mn |
| Dec 31, 2023 | 13.91 Mn |
| Sep 30, 2023 | 10.38 Mn |
| Jun 30, 2023 | 8.62 Mn |
| Mar 31, 2023 | 8.47 Mn |
| Dec 31, 2022 | 5.61 Mn |
| Sep 30, 2022 | 6.24 Mn |
| Jun 30, 2022 | 6.78 Mn |
| Mar 31, 2022 | 5.77 Mn |
| Dec 31, 2021 | 3.00 Mn |
| Sep 30, 2021 | 8.29 Mn |
| Jun 30, 2021 | 11.09 Mn |